Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Viventia Bio Inc.
1534
Viventia Bio Inc.
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
Viventia Bio is the leader in developing next generation oncology therapeutics utilizing our proprietary Targeted Protein Therapeutic technology (TPT).
Suggest edits
Follow us
Companies in the same industry
Hyasynth Bio
Athersys Inc
Aratana Therapeutics
Prospective Research
Syntimmune
Ironwood Pharma
Ritter Pharmaceuticals, Inc.
Ultragenyx Pharmaceutical
GTx, Inc.
eXIthera Pharmaceuticals
Alexa global traffic share
Overview
Add info
Acquired by
2
21 Sep 2016
Eleven Biotherapeutics
Location
Canada
Headquarters
Explore Canada
Acquisition
Seeking Alpha
,
businesswire
Eleven Biotherapeutics acquires Viventia Bio in all-stock deal
